Screening for Lipid Disorders in Children and Adolescents
医学
儿科
作者
Michael J. Barry,Wanda K Nicholson,Michael Silverstein,David Chelmow,Tumaini R. Coker,Esa M. Davis,Katrina E Donahue,Carlos Roberto Jaén,Li Li,Gbenga Ogedegbe,Goutham Rao,John Ruiz,James J. Stevermer,Joel Tsevat,Sandra Millon Underwood
出处
期刊:JAMA [American Medical Association] 日期:2023-07-18卷期号:330 (3): 253-253被引量:11
Importance Familial hypercholesterolemia and multifactorial dyslipidemia are 2 conditions that cause abnormally high lipid levels in children, which can lead to premature cardiovascular events (eg, myocardial infarction and stroke) and death in adulthood. Objective The US Preventive Services Task Force (USPSTF) commissioned a systematic review to evaluate the benefits and harms of screening for lipid disorders in asymptomatic children and adolescents. Population Asymptomatic children and adolescents 20 years or younger without a known diagnosis of a lipid disorder. Evidence Assessment The USPSTF concludes that the current evidence is insufficient and the balance of benefits and harms for screening for lipid disorders in asymptomatic children and adolescents 20 years or younger cannot be determined. Recommendation The USPSTF concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for lipid disorders in children and adolescents 20 years or younger. (I statement)